About: Axomadol

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Axomadol (INN, USAN) (code name EN3324) is a synthetic, centrally-acting opioid analgesic of the benzenoid class which was under investigation by Endo Pharmaceuticals in collaboration with Grünenthal for the treatment of chronic, moderate to severe lower back pain and arthrosis. Development was halted after phase II clinical trials as it did not meet the pre-determined clinical endpoints.

Property Value
dbo:abstract
  • Axomadol (INN, USAN) (code name EN3324) is a synthetic, centrally-acting opioid analgesic of the benzenoid class which was under investigation by Endo Pharmaceuticals in collaboration with Grünenthal for the treatment of chronic, moderate to severe lower back pain and arthrosis. Development was halted after phase II clinical trials as it did not meet the pre-determined clinical endpoints. (en)
dbo:casNumber
  • 187219-95-0
  • 187219-99-4
dbo:fdaUniiCode
  • B77S5W28H9
dbo:pubchem
  • 10221318
dbo:thumbnail
dbo:wikiPageID
  • 35794807 (xsd:integer)
dbo:wikiPageLength
  • 2926 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1082619103 (xsd:integer)
dbo:wikiPageWikiLink
dbp:atcPrefix
  • None (en)
dbp:c
  • 16 (xsd:integer)
dbp:casNumber
  • 187219 (xsd:integer)
dbp:casSupplemental
  • 187219 (xsd:integer)
dbp:chemspiderid
  • 8396810 (xsd:integer)
dbp:h
  • 25 (xsd:integer)
dbp:iupacName
  • -6 (xsd:integer)
dbp:legalUs
  • IND (en)
dbp:n
  • 1 (xsd:integer)
dbp:o
  • 3 (xsd:integer)
dbp:pubchem
  • 10221318 (xsd:integer)
dbp:smiles
  • O[C@]2C[C@H]CC[C@@H]2CNC (en)
dbp:stdinchi
  • 1 (xsd:integer)
dbp:stdinchikey
  • LQJLLAOISDVBJM-FMKPAKJESA-N (en)
dbp:unii
  • B77S5W28H9 (en)
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • Axomadol (INN, USAN) (code name EN3324) is a synthetic, centrally-acting opioid analgesic of the benzenoid class which was under investigation by Endo Pharmaceuticals in collaboration with Grünenthal for the treatment of chronic, moderate to severe lower back pain and arthrosis. Development was halted after phase II clinical trials as it did not meet the pre-determined clinical endpoints. (en)
rdfs:label
  • Axomadol (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License
  NODES
INTERN 1